Clinical efficacy of minimal access retroperitoneal pancreatic necrosectomy for infected pancreatic necrosis

Q4 Medicine
Wei Zhou, J. Cui, S. Gou, T. Yin, J. Xiong, Chun-you Wang
{"title":"Clinical efficacy of minimal access retroperitoneal pancreatic necrosectomy for infected pancreatic necrosis","authors":"Wei Zhou, J. Cui, S. Gou, T. Yin, J. Xiong, Chun-you Wang","doi":"10.3760/CMA.J.ISSN.1673-9752.2019.10.010","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the clinical efficacy of minimal access retroperitoneal pancreatic necrosectomy (MARPN) for infected pancreatic necrosis (IPN). \n \n \nMethods \nThe retrospective cohort study was conducted. The clinical data of 61 patients with IPN who were admitted to Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology between January 2014 and December 2017 were collected. There were 39 males and 22 females, aged 36-67 years, with a median age of 49 years. Of 61 patients, 40 undergoing open surgery were allocated into open group, and 21 undergoing MARPN were allocated into MARPN group. All the patients underwent surgical treatments after standard non-surgical treatments according to the Guidelines for the diagnosis and treatment of severe acute pancreatitis (2014 edition). Observation indicators: (1) intraoperative and postoperative situations; (2) follow-up. Follow-up using telephone interview or outpatient examination was performed to detect weight loss, pathoglycemia, steatorrhea, intestinal obstruction, and pancreatic portal hypertension for one year after surgery up to December 2017. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was analyzed using the t test. Count data were represented as absolute numbers or percentages, and comparison between groups was done using the chi-square test. \n \n \nResults \n(1) Intraoperative and postoperative situations: operation time, time to out-of-bed activity, time to initial food intake, cases with reoperation, cases with postoperative multiple organ dysfunction syndrome (MODS), incidence rate of postoperative complications, mortality, time to drainage-tube removal, duration of hospital stay, and hospital expenses were (77±20)minutes, (13.0±3.6)days, (9.0±2.7)days, 8, 9, 45.0%(18/40), 7.5%(3/40), (37.0±6.3)days, (49±8)days, (84 321±8 872)yuan in the open group, and (59±20)minutes, (2.7±0.9)days, (1.9±0.4)days, 6, 2, 19.0%(4/21), 0, (21.0±2.7)days, (39±6)days, (58 594±3 576)yuan in the MARPN group, respectively, showing no significant difference in the cases with reoperation (χ2=0.69, P>0.05) but significant differences in the other indices between the two groups (t=4.24, 9.61, 15.34, χ2=23.76, 4.02, 36.03, t=11.07, 5.93, 8.43, P 0.05). \n \n \nConclusion \nMARPN for IPN is safe and reliable, with certain efficacy, which can effectively reduce incidence of postoperative complication, motality and shorten hospital stay. \n \n \nKey words: \nPancreatitis; Infection; Retroperitoneal approach; Pancreatic necrosectomy","PeriodicalId":36400,"journal":{"name":"中华消化外科杂志","volume":"18 1","pages":"946-950"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华消化外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-9752.2019.10.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To investigate the clinical efficacy of minimal access retroperitoneal pancreatic necrosectomy (MARPN) for infected pancreatic necrosis (IPN). Methods The retrospective cohort study was conducted. The clinical data of 61 patients with IPN who were admitted to Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology between January 2014 and December 2017 were collected. There were 39 males and 22 females, aged 36-67 years, with a median age of 49 years. Of 61 patients, 40 undergoing open surgery were allocated into open group, and 21 undergoing MARPN were allocated into MARPN group. All the patients underwent surgical treatments after standard non-surgical treatments according to the Guidelines for the diagnosis and treatment of severe acute pancreatitis (2014 edition). Observation indicators: (1) intraoperative and postoperative situations; (2) follow-up. Follow-up using telephone interview or outpatient examination was performed to detect weight loss, pathoglycemia, steatorrhea, intestinal obstruction, and pancreatic portal hypertension for one year after surgery up to December 2017. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was analyzed using the t test. Count data were represented as absolute numbers or percentages, and comparison between groups was done using the chi-square test. Results (1) Intraoperative and postoperative situations: operation time, time to out-of-bed activity, time to initial food intake, cases with reoperation, cases with postoperative multiple organ dysfunction syndrome (MODS), incidence rate of postoperative complications, mortality, time to drainage-tube removal, duration of hospital stay, and hospital expenses were (77±20)minutes, (13.0±3.6)days, (9.0±2.7)days, 8, 9, 45.0%(18/40), 7.5%(3/40), (37.0±6.3)days, (49±8)days, (84 321±8 872)yuan in the open group, and (59±20)minutes, (2.7±0.9)days, (1.9±0.4)days, 6, 2, 19.0%(4/21), 0, (21.0±2.7)days, (39±6)days, (58 594±3 576)yuan in the MARPN group, respectively, showing no significant difference in the cases with reoperation (χ2=0.69, P>0.05) but significant differences in the other indices between the two groups (t=4.24, 9.61, 15.34, χ2=23.76, 4.02, 36.03, t=11.07, 5.93, 8.43, P 0.05). Conclusion MARPN for IPN is safe and reliable, with certain efficacy, which can effectively reduce incidence of postoperative complication, motality and shorten hospital stay. Key words: Pancreatitis; Infection; Retroperitoneal approach; Pancreatic necrosectomy
小切口腹膜后胰腺坏死切除术治疗感染性胰腺坏死的临床疗效
目的探讨小切口腹膜后胰腺坏死切除术(MARPN)治疗感染性胰腺坏死(IPN)的临床疗效。方法采用回顾性队列研究。收集2014年1月至2017年12月华中科技大学同济医学院附属协和医院收治的61例IPN患者的临床资料。男性39例,女性22例,年龄36 ~ 67岁,中位年龄49岁。61例患者中,40例行开放手术分为开放组,21例行MARPN手术分为MARPN组。所有患者均按照《严重急性胰腺炎诊治指南(2014年版)》进行标准非手术治疗后行手术治疗。观察指标:(1)术中、术后情况;(2)跟进。术后随访1年至2017年12月,采用电话随访或门诊检查,检测体重减轻、血糖升高、脂肪漏、肠梗阻和胰门脉高压。计量资料为正态分布,用Mean±SD表示,组间比较采用t检验。计数资料以绝对数字或百分比表示,组间比较采用卡方检验。(1)术中及术后情况:手术时间、下床活动时间、开始进食时间、再手术病例数、术后多器官功能障碍(MODS)病例数、术后并发症发生率、死亡率、拔管时间、住院时间、住院费用分别为(77±20)分钟、(13.0±3.6)天、(9.0±2.7)天、8、9、45.0%(18/40)、7.5%(3/40)、(37.0±6.3)天、(49±8)天、(84 321±8 872)元,开放组为(59±20)分钟、(2.7±0.9)天。MARPN组分别为(1.9±0.4)天、6、2、19.0%(4/21)、0、(21.0±2.7)天、(39±6)天、(58 594±3 576)元,再手术例数差异无统计学意义(χ2=0.69, P < 0.05),但两组间其他指标差异有统计学意义(t=4.24、9.61、15.34,χ2=23.76、4.02、36.03,t=11.07、5.93、8.43,P < 0.05)。结论MARPN治疗IPN安全可靠,具有一定疗效,可有效降低术后并发症发生率、死亡率、缩短住院时间。关键词:胰腺炎;感染;腹膜后途径;胰腺进行
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华消化外科杂志
中华消化外科杂志 Medicine-Gastroenterology
CiteScore
0.50
自引率
0.00%
发文量
4544
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信